Occult HBV reactivation induced by ibrutinib treatment: a case report.

Détails

ID Serval
serval:BIB_A5DB1D3900B6
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Titre
Occult HBV reactivation induced by ibrutinib treatment: a case report.
Périodique
Acta Gastro-enterologica Belgica
Auteur⸱e⸱s
de Jésus Ngoma P., Kabamba B., Dahlqvist G., Sempoux C., Lanthier N., Shindano T., Van Den Neste E., Horsmans Y.
ISSN
1784-3227 (Print)
ISSN-L
1784-3227
Statut éditorial
Publié
Date de publication
2015
Peer-reviewed
Oui
Volume
78
Numéro
4
Pages
424-426
Langue
anglais
Notes
Publication types: Case Reports ; Journal ArticlePublication Status: ppublish
Résumé
Ibrutinib is a small molecule that has been recently developped for the treatment of B cell malignancies. Common side effects are diarrhoea, nausea, fatigue, infections, neutropenia and thrombocytopenia. Here we report the first case of Hepatitis B virus reactivation in a 80 years old chronic lymphocytic leukaemia patient receiving ibrutinib, suggesting that such treatment must be associated with HBV screening.
Mots-clé
Aged, 80 and over, Hepatitis B/etiology, Hepatitis B/pathology, Humans, Leukemia, Lymphocytic, Chronic, B-Cell/complications, Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy, Male, Pyrazoles/adverse effects, Pyrimidines/adverse effects, Virus Activation
Pubmed
Web of science
Création de la notice
20/10/2016 16:30
Dernière modification de la notice
20/08/2019 16:10
Données d'usage